Lianting Chen on Muck Rack

Lianting Chen

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lianting

Contact Lianting, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

|
By Wei Liu, Hesong Zou, Wenyang Huang, Lianting Chen
| bmj.com
Subjects and methods In this phase I/II clinical trial, transplantation-eligible patients with LBCL who were refractory to a first-line rituximab-containing anthracycline-based chemotherapy regimen and/or who had an R/R status after at least two cycles of salvage chemotherapy were included. (Detailed inclusion and exclusion criteria are listed in the Methods section of online supplemental appendix).
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified